ADBiotech Co., Ltd. (KOSDAQ:179530)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,650.00
-25.00 (-0.93%)
At close: Apr 28, 2026

ADBiotech Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020
Cash & Equivalents
3,913638.533,0151,1791,195
Upgrade
Short-Term Investments
6306306304,547120
Upgrade
Trading Asset Securities
6,926410.725,7692,9011,465
Upgrade
Cash & Short-Term Investments
11,4701,6799,4148,6282,781
Upgrade
Cash Growth
583.01%-82.16%9.11%210.28%-2.17%
Upgrade
Accounts Receivable
1,9612,9301,5961,8733,497
Upgrade
Other Receivables
109.3108.468.0747.673.28
Upgrade
Receivables
5,9893,0391,6042,3213,500
Upgrade
Inventory
2,2932,3752,2652,9522,106
Upgrade
Prepaid Expenses
1,031152.1116.8359.2781.21
Upgrade
Other Current Assets
70.841,144117.63163.87204.67
Upgrade
Total Current Assets
20,8548,39013,41714,1238,672
Upgrade
Property, Plant & Equipment
10,18211,06110,31210,31910,287
Upgrade
Long-Term Investments
1,7851,9231,5856,4911,878
Upgrade
Goodwill
-704.451,126--
Upgrade
Other Intangible Assets
31.69898.151,0292.45.11
Upgrade
Long-Term Accounts Receivable
0---0
Upgrade
Other Long-Term Assets
15,55598.42623.5183117.09
Upgrade
Total Assets
48,40723,07428,09331,01820,959
Upgrade
Accounts Payable
1,7011,669250.65386.051,116
Upgrade
Accrued Expenses
417.87336.03212.78250.12341.01
Upgrade
Short-Term Debt
12,9046,9859,1429,5439,147
Upgrade
Current Portion of Long-Term Debt
831.64653.96399.08166.56773.78
Upgrade
Current Portion of Leases
37.9860.7289.3821.0919.92
Upgrade
Other Current Liabilities
13,7493,7971,1741,4261,229
Upgrade
Total Current Liabilities
29,64113,50111,26811,79312,626
Upgrade
Long-Term Debt
3,0273,8593,5133,0123,179
Upgrade
Long-Term Leases
0.77413.32466.2428.149.18
Upgrade
Pension & Post-Retirement Benefits
57.354771.92--
Upgrade
Long-Term Deferred Tax Liabilities
303.68483.29205.32--
Upgrade
Other Long-Term Liabilities
000--
Upgrade
Total Liabilities
33,03118,30415,52514,83315,854
Upgrade
Common Stock
8,1804,5704,5704,5703,847
Upgrade
Additional Paid-In Capital
35,61725,55727,25727,25718,293
Upgrade
Retained Earnings
-27,672-24,381-16,431-13,574-16,270
Upgrade
Comprehensive Income & Other
-802.69-909.44-2,004-2,068-763.03
Upgrade
Total Common Equity
15,3234,83713,39316,1855,106
Upgrade
Minority Interest
-1,783-1,862-2,545--
Upgrade
Shareholders' Equity
15,3774,77112,56916,1855,106
Upgrade
Total Liabilities & Equity
48,40723,07428,09331,01820,959
Upgrade
Total Debt
16,80211,97213,61012,77113,168
Upgrade
Net Cash (Debt)
-5,332-10,292-4,196-4,143-10,388
Upgrade
Net Cash Per Share
-443.82-1126.04-459.08-410.96-1351.57
Upgrade
Filing Date Shares Outstanding
14.49.149.149.147.69
Upgrade
Total Common Shares Outstanding
14.49.149.149.147.69
Upgrade
Working Capital
-8,788-5,1112,1492,330-3,954
Upgrade
Book Value Per Share
1063.73529.161465.201770.73663.67
Upgrade
Tangible Book Value
15,2913,23411,23716,1835,100
Upgrade
Tangible Book Value Per Share
1061.53353.831229.371770.47663.00
Upgrade
Land
5,4465,3213,8683,868641.06
Upgrade
Buildings
4,0614,1924,3234,4554,586
Upgrade
Machinery
489.7967.431,4111,7292,201
Upgrade
Construction In Progress
25.6-14.4117.472,784
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.